{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:35:11Z","timestamp":1775583311461,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012219","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000}}],"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Onchocerciasis remains an important public health problem targeted for elimination in Tanzania. Ulanga District was hyperendemic for onchocerciasis before the intervention, underscoring the need for particularly high coverage in MDA efforts. The district has been implementing MDA through Community Directed Treatment with Ivermectin (CDTI) strategy since 1998. However, there is preliminary evidence of persistent onchocerciasis transmission, which likely sustains the observed high prevalence of Onchocerciasis in both human and vector species. This could be linked to poor treatment coverage. This study was conducted to assess treatment coverage and explore factors that determine drug uptake during MDA program.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A cross-sectional study was conducted in Ulanga District, Morogoro, Tanzania, from April to June 2019. Using multistage cluster sampling, 502 participants were randomly selected and interviewed through a structured questionnaire. Modified Poisson regression analysis was used to identify independent factors affecting MDA uptake.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The overall response rate was 96% with majority (67%) of respondents being females, and the mean age of the study participants was 37.8 years with a standard deviation (SD) of\u2009\u00b1\u200915 years. The study found that MDA coverage varied across villages: Mawasiliano (68%, CI: 59.3 \u2013 75.6), Uponera (83%, CI; 76.6 \u2013 89.6), Isongo (84.8%, CI: 77.3 \u2013 90.1) and Togo (79%, CI: 70.1 \u2013 85.8). While Uponera and Isongo achieved the WHO-recommended 80% coverage for transmission interruption, Mawasiliano and Togo fell below this threshold. Age significantly influenced drug uptake, with younger individuals (15\u201324 years) having a lower uptake rate [APR\u2009=\u20092.8, p\u2009=\u20090.008], followed by the 25\u201334 age group [APR\u2009=\u20092.3, p\u2009=\u20090.04]. Occupation also played a role, as small and medium enterprise (SME) workers [APR\u2009=\u20093.2, p\u2009=\u20090.05] and students [APR\u2009=\u20092.9, p\u2009=\u20090.05] were less likely to participate. Residence duration in the village was a strong predictor of MDA uptake. Individuals living in the village for more than a year were significantly more likely to participate [APR\u2009=\u20092.3, p\u2009=\u20090.00]. Additionally, a lack of awareness about MDA benefits negatively impacted participation, as those uncertain about its benefits were less likely to take the drug [APR\u2009=\u20092.5, p\u2009=\u20090.03]. Similarly, individuals unaware of the correct MDA distribution schedule had lower uptake [APR\u2009=\u20092.5, p\u2009=\u20090.03]. However, those who took Ivermectin for prevention purposes were significantly more likely to participate [APR\u2009=\u200913.4, p\u2009=\u20090.001].<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>MDA coverage below the WHO optimally recommended coverage has been demonstrated in the villages studied. This implies low drug uptake, delayed interruption of transmission and Onchocerciasis elimination. The findings highlight the need for targeted interventions to improve MDA coverage by focusing on younger individuals, certain occupational groups, and new residents. Strengthening community engagement, improving health communication, and intensifying biannual MDA efforts are recommended to accelerate Onchocerciasis elimination in the district. It also underscores the need for adopting other effective public health interventions such as community mobilization towards slash and clear of potential breeding sites for Onchocerciasis vector.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0012219","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:39:58Z","timestamp":1744738798000},"page":"e0012219","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mass drug administration coverage and its determinants for the elimination of onchocerciasis in Ulanga District, Tanzania"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0644-8342","authenticated-orcid":true,"given":"Ambakisye Kuyokwa","family":"Mhiche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinah","family":"Gasarasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ally","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendo John","family":"Mwingira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Mohamed","family":"Abade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"pntd.0012219.ref001","doi-asserted-by":"crossref","first-page":"748540","DOI":"10.1155\/2012\/748540","article-title":"Transmission of onchocerciasis in wadelai focus of northwestern Uganda has been interrupted and the disease eliminated","volume":"2012","author":"MN Katabarwa","year":"2012","journal-title":"J Parasitol Res"},{"key":"pntd.0012219.ref002","volume-title":"Onchocerciasis (River Blindness), vol. 2","author":"D Onchocerciasis","year":"1947"},{"issue":"12","key":"pntd.0012219.ref003","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1371\/journal.pntd.0002562","article-title":"Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts","volume":"7","author":"JD Keenan","year":"2013","journal-title":"PLoS neglected tropical diseases"},{"key":"pntd.0012219.ref004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.actatropica.2016.12.029","article-title":"Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding","volume":"167","author":"T Lakwo","year":"2017","journal-title":"Acta Trop"},{"issue":"5","key":"pntd.0012219.ref005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-3156.2011.02735.x","article-title":"Where would I be without ivermectin? Capturing the benefits of community-directed treatment with ivermectin in Africa","volume":"16","author":"JC Okeibunor","year":"2011","journal-title":"Trop Med Int Health"},{"key":"pntd.0012219.ref006","first-page":"1","article-title":"Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections","author":"HC Turner","year":"2014","journal-title":"Parasites & Vectors"},{"key":"pntd.0012219.ref007","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.epidem.2017.02.002","article-title":"Measuring and modelling the effects of systematic non-adherence to mass drug administration.","volume":"18","author":"L Dyson","year":"2017","journal-title":"Epidemics"},{"issue":"8","key":"pntd.0012219.ref008","doi-asserted-by":"crossref","first-page":"e0005849","DOI":"10.1371\/journal.pntd.0005849","article-title":"Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs","volume":"11","author":"FN Dissak-Delon","year":"2017","journal-title":"PLoS neglected tropical diseases"},{"issue":"1","key":"pntd.0012219.ref009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1179\/136485908X252241","article-title":"Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south\u2013eastern Nigeria","volume":"102","author":"EC Emukah","year":"2008","journal-title":"Annals of Tropical Medicine & Parasitology"},{"key":"pntd.0012219.ref010","first-page":"1","article-title":"Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria","author":"WR Brieger","year":"2011","journal-title":"Parasites & vectors"},{"key":"pntd.0012219.ref011","first-page":"681","volume-title":"Weekly Epidemiological Record","author":"P Cantey","year":"2017"},{"key":"pntd.0012219.ref012","first-page":"445","article-title":"Weekly epidemiological record: relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire","volume":"3","author":"M Donadeu","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"pntd.0012219.ref013","unstructured":"Hollows F, International HK. Tanzania Work Plan. 2019; (October 2015)."},{"key":"pntd.0012219.ref014","volume-title":"Report of the twenty-eighth session of the Technical Consultative Committee (TCC): Ouagadougou, 09-14 March 2009. In Report of the twenty-eighth session of the Technical Consultative Committee (TCC): Ouagadougou, 09-14 March 2009","author":"World Health Organization"},{"key":"pntd.0012219.ref015","doi-asserted-by":"crossref","first-page":"1079012","DOI":"10.3389\/fitd.2023.1079012","article-title":"Factorsassociated with low-uptake of ivermectin in Mahenge, an area with high prevalence of onchocerciasis and epilepsy in Tanzania: A qualitative perspective","volume":"4","author":"D Bhwana","year":"2023","journal-title":"Frontiers in Tropical Diseases"},{"key":"pntd.0012219.ref016","doi-asserted-by":"crossref","first-page":"108568","DOI":"10.1016\/j.yebeh.2022.108568","article-title":"Community knowledge, attitudes, and practices regarding epilepsy in Mahenge, Tanzania: A socio-anthropological study in an onchocerciasis-endemic area with a high prevalence of epilepsy","volume":"128","author":"BP Mmbando","year":"2022","journal-title":"Epilepsy & Behavior"},{"issue":"12","key":"pntd.0012219.ref017","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/pathogens10121588","article-title":"Treatment of pregnant women with ivermectin during mass drug distribution: time to investigate its safety and potential benefits","volume":"10","author":"AC Erber","year":"2021","journal-title":"Pathogens"},{"issue":"3","key":"pntd.0012219.ref018","doi-asserted-by":"crossref","first-page":"e0009144","DOI":"10.1371\/journal.pntd.0009144","article-title":"A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication","volume":"15","author":"P Jittamala","year":"2021 Mar 17","journal-title":"PLoS neglected tropical diseases"},{"issue":"3","key":"pntd.0012219.ref019","doi-asserted-by":"crossref","first-page":"e017188","DOI":"10.1136\/bmjopen-2017-017188","article-title":"Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years","volume":"8","author":"H Greter","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"pntd.0012219.ref020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40249-018-0450-3","article-title":"High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin","volume":"7","author":"BP Mmbando","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"pntd.0012219.ref021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2018.01.009","article-title":"The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania","volume":"181","author":"A Hendy","year":"2018","journal-title":"Acta tropica"},{"key":"pntd.0012219.ref022","volume-title":"A simplified general method for cluster-sample surveys of health in developing countries","author":"S Bennett"},{"issue":"2","key":"pntd.0012219.ref023","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.inhe.2009.08.008","article-title":"Perceptions on onchocerciasis and ivermectin treatment in rural communities in Uganda: implications for long-term compliance","volume":"1","author":"R Ndyomugyenyi","year":"2009","journal-title":"Int Health"},{"issue":"7","key":"pntd.0012219.ref024","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-3156.2005.01436.x","article-title":"Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results","volume":"10","author":"F Nuwaha","year":"2005","journal-title":"Trop Med Int Health"},{"issue":"2","key":"pntd.0012219.ref025","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.3402\/qhw.v6i2.5918","article-title":"Drawing and interpreting data: Children\u2019s impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa","volume":"6","author":"M Amuyunzu-Nyamongo","year":"2011","journal-title":"International journal of qualitative studies on health and well-being"},{"issue":"8","key":"pntd.0012219.ref026","doi-asserted-by":"crossref","first-page":"e0004905","DOI":"10.1371\/journal.pntd.0004905","article-title":"Factors associated with ivermectin non-compliance and its potential role in sustaining Onchocerca volvulus transmission in the west region of Cameroon","volume":"10","author":"L Senyonjo","year":"2016","journal-title":"PLoS neglected tropical diseases"},{"key":"pntd.0012219.ref027","volume-title":"Certification of elimination of human onchocerciasis: criteria and procedures","author":"World Health Organization","year":"2001"},{"issue":"7","key":"pntd.0012219.ref028","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-3156.2012.03007.x","article-title":"Characteristics of persons who complied with and failed to comply with annual ivermectin treatment","volume":"17","author":"WR Brieger","year":"2012","journal-title":"Trop Med Int Health"},{"key":"pntd.0012219.ref029","unstructured":"Njomo D, Amuyunzu-Nyamongo M, Mukoko D, Magambo J, Njenga S. Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: descriptive study results."},{"issue":"3","key":"pntd.0012219.ref030","first-page":"272","article-title":"Research for new drugs for elimination of onchocerciasis in Africa","volume":"6","author":"AC Kuesel","year":"2016","journal-title":"International Journal for Parasitology: Drugs and Drug Resistance"},{"issue":"4","key":"pntd.0012219.ref031","first-page":"509","article-title":"Recent developments in the treatment of onchocerciasis","volume":"62","author":"HR Taylor","year":"1984","journal-title":"Bulletin of the World Health Organization"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012219","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:50:56Z","timestamp":1746208256000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012219"}},"subtitle":[],"editor":[{"given":"Chao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012219","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0012219","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}